Top Questions in ID: Pre-exposure Prophylaxis for HIV

HIV pre-exposure prophylaxis (PrEP) is highly efficacious at preventing HIV acquisition. This review discusses ways to identify candidates for PrEP, recommended PrEP regimens, baseline and follow-up evaluations, applications of PrEP for HIV-serodiscordant couples, resources to address financial barr...

Descripción completa

Detalles Bibliográficos
Autores principales: Krakower, Douglas S, Cohen, Stephanie E, Mayer, Kenneth H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Top Questions in ID
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5632308/
https://www.ncbi.nlm.nih.gov/pubmed/29026872
http://dx.doi.org/10.1093/ofid/ofx185
_version_ 1783269675940970496
author Krakower, Douglas S
Cohen, Stephanie E
Mayer, Kenneth H
author_facet Krakower, Douglas S
Cohen, Stephanie E
Mayer, Kenneth H
author_sort Krakower, Douglas S
collection PubMed
description HIV pre-exposure prophylaxis (PrEP) is highly efficacious at preventing HIV acquisition. This review discusses ways to identify candidates for PrEP, recommended PrEP regimens, baseline and follow-up evaluations, applications of PrEP for HIV-serodiscordant couples, resources to address financial barriers, investigational strategies for PrEP, and educational resources for clinicians and patients.
format Online
Article
Text
id pubmed-5632308
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-56323082017-10-12 Top Questions in ID: Pre-exposure Prophylaxis for HIV Krakower, Douglas S Cohen, Stephanie E Mayer, Kenneth H Open Forum Infect Dis Top Questions in ID HIV pre-exposure prophylaxis (PrEP) is highly efficacious at preventing HIV acquisition. This review discusses ways to identify candidates for PrEP, recommended PrEP regimens, baseline and follow-up evaluations, applications of PrEP for HIV-serodiscordant couples, resources to address financial barriers, investigational strategies for PrEP, and educational resources for clinicians and patients. Oxford University Press 2017-08-25 /pmc/articles/PMC5632308/ /pubmed/29026872 http://dx.doi.org/10.1093/ofid/ofx185 Text en © The Author 2017. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Top Questions in ID
Krakower, Douglas S
Cohen, Stephanie E
Mayer, Kenneth H
Top Questions in ID: Pre-exposure Prophylaxis for HIV
title Top Questions in ID: Pre-exposure Prophylaxis for HIV
title_full Top Questions in ID: Pre-exposure Prophylaxis for HIV
title_fullStr Top Questions in ID: Pre-exposure Prophylaxis for HIV
title_full_unstemmed Top Questions in ID: Pre-exposure Prophylaxis for HIV
title_short Top Questions in ID: Pre-exposure Prophylaxis for HIV
title_sort top questions in id: pre-exposure prophylaxis for hiv
topic Top Questions in ID
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5632308/
https://www.ncbi.nlm.nih.gov/pubmed/29026872
http://dx.doi.org/10.1093/ofid/ofx185
work_keys_str_mv AT krakowerdouglass topquestionsinidpreexposureprophylaxisforhiv
AT cohenstephaniee topquestionsinidpreexposureprophylaxisforhiv
AT mayerkennethh topquestionsinidpreexposureprophylaxisforhiv

Ejemplares similares